Healthcare provider profile · identity verified

Guy Alexander Fogg, MD

Internal Medicine · INDEPENDENCE, MO · NPI 1881071124

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	274	99
Lisinopril	Lisinopril	177	60
Albuterol Sulfate Hfa	Albuterol Sulfate	160	56
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	151	34
Levothyroxine Sodium	Levothyroxine Sodium	135	42
Gabapentin	Gabapentin	133	39
Amlodipine Besylate	Amlodipine Besylate	127	49
Rosuvastatin Calcium	Rosuvastatin Calcium	116	49
Losartan Potassium	Losartan Potassium	114	34
Duloxetine Hcl	Duloxetine Hcl	105	33
Prednisone	Prednisone	89	39
Alendronate Sodium	Alendronate Sodium	87	28
Carvedilol	Carvedilol	83	24
Jardiance	Empagliflozin	81	27
Omeprazole	Omeprazole	79	31
Pantoprazole Sodium	Pantoprazole Sodium	79	24
Metformin Hcl	Metformin Hcl	78	33
Trazodone Hcl	Trazodone Hcl	76	23
Furosemide	Furosemide	71	24
Mirtazapine	Mirtazapine	71	23
Tramadol Hcl	Tramadol Hcl	71	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	63	13
Montelukast Sodium	Montelukast Sodium	62	21
Metoprolol Succinate	Metoprolol Succinate	61	20
Famotidine	Famotidine	57	27
Pregabalin	Pregabalin	56	16
Ozempic	Semaglutide	55	12
Spironolactone	Spironolactone	54	18
Tizanidine Hcl	Tizanidine Hcl	54	27
Tamsulosin Hcl	Tamsulosin Hcl	51	23
Sertraline Hcl	Sertraline Hcl	50	17
Clopidogrel	Clopidogrel Bisulfate	49	15
Fluticasone Propionate	Fluticasone Propionate	48	18
Meloxicam	Meloxicam	48	14
Eliquis	Apixaban	46	14
Buspirone Hcl	Buspirone Hcl	41	17
Oxybutynin Chloride	Oxybutynin Chloride	41	12
Ezetimibe	Ezetimibe	39	15
Varenicline Tartrate	Varenicline Tartrate	39	12
Metformin Hcl Er	Metformin Hcl	38	16
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Simvastatin	Simvastatin	33	11
Diazepam	Diazepam	32	suppressed
Allopurinol	Allopurinol	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	12
Alprazolam	Alprazolam	29	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	22
Bupropion Xl	Bupropion Hcl	28	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	28	14
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	27	27
Metoprolol Tartrate	Metoprolol Tartrate	26	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	26	23
Azelastine Hcl	Azelastine Hcl	25	16
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	25	suppressed
Glimepiride	Glimepiride	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	11
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Finasteride	Finasteride	18	suppressed
Glipizide	Glipizide	18	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Potassium Chloride	Potassium Chloride	17	suppressed
Temazepam	Temazepam	17	suppressed
Torsemide	Torsemide	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Azithromycin	Azithromycin	16	14
Terazosin Hcl	Terazosin Hcl	16	suppressed
Ciclopirox	Ciclopirox	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Naproxen	Naproxen	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Colchicine	Colchicine	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Aimovig Autoinjector	Erenumab-Aooe	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Methimazole	Methimazole	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error